National Cancer Institute - Cancer.gov

By the Numbers

Take a look at our year as told by the numbers to see a snapshot of the breakthrough scientific discoveries and important work happening at CCR.

decorative graphic
386
Open Clinical Trials
42
New Clinical Trials
1,487
New Patients
decorative graphic
238
Principal Investigators
5
New Faculty Recruits*
3
Newly Tenured Investigators*
321/82
Staff Scientists/Staff Clinicians
~600
Technical Lab Staff
802/97
Postdoctoral/Clinical Fellows
392/45
Postbaccalaureate/Predoctoral Students
187
Summer Students
decorative graphic
>1,000
Articles in Peer-Reviewed Journals
decorative graphic
64
Technology Facilities and Platforms
Technology Transfer Activities
decorative graphic
71
New Employee Invention Reports
46
Issued U.S. Patents
23
New Cooperative Research and Development Agreements (CRADAs)
176
Active CRADAs
90
Clinical CRADAs
7
Umbrella CRADAs
16
New Clinical Trial Agreements (CTAs)
118
Active CTAs
decorative graphic
101
New Licenses for CCR Technologies
708
Active Licenses
decorative graphic
2
FDA Approvals**

The NCI Technology Transfer Center (TTC) works to enable and guide collaboration, invention development and licensing to advance today’s discoveries into tomorrow’s medical care. The TTC supports technology development activities for NCI in therapeutics, diagnostics, research tools, vaccines, devices, software and facilitates partnerships with outside organizations so that NCI discoveries can reach the public in a timely manner. 

For information on licensing and co-development opportunities, contact the TTC Invention Development and Marketing Unit (ncitechtransfer@mail.nih.gov).  

Numbers are for fiscal year 2024 unless otherwise marked. 
*Numbers are for calendar year 2024.  
**Path to approval supported by CCR co-developed agents and/or collaborations.